You have 9 free searches left this month | for more free features.

Liver Metastasis Colon Cancer

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HepaSphere™ Microspheres Prospective Registry

Completed
  • Metastatic Colorectal Cancer
  • HepaSphere Microspheres
  • Paris, France
  • +1 more
Jul 16, 2021

Peripheral Neuropathy, Chemo-induced Peripheral Neuropathy, Breast Cancer Trial in Alexandria (Lidocaine in Saline, Duloxetine

Completed
  • Peripheral Neuropathy
  • +2 more
  • Lidocaine in Saline
  • +2 more
  • Alexandria, Egypt
    Egypt Medical Research Institute
Jul 7, 2022

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022

Metastatic Castration Resistant Prostate Cancer Trial in New York, Pittsburgh, Seoul (DZD2269)

Terminated
  • Metastatic Castration Resistant Prostate Cancer
  • New York, New York
  • +5 more
Jul 6, 2022

Liver Transplantation Trial (ADVAGRAF®)

Completed
  • Liver Transplantation
  • (no location specified)
Feb 17, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +21 more
  • Scottsdale, Arizona
  • +2 more
May 31, 2022

NSCLC Trial in Worldwide (Osimertinib, Cisplatin, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer
  • Birmingham, Alabama
  • +222 more
Dec 7, 2022

Colorectal Adenocarcinoma Trial in Puerto Rico, United States (drug, dietary supplement, other)

Recruiting
  • Colorectal Adenocarcinoma
  • Birmingham, Alabama
  • +1030 more
Sep 25, 2022

Breast Cancer, Breast Cancer Female, Breast Cancer Stage II Trial in Boston (Accelerated Proton Beam Radiation Therapy (PBT),

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Accelerated Proton Beam Radiation Therapy (PBT)
  • Accelerated Photon Radiation Therapy (XRT)
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jun 12, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jul 14, 2022

Metastatic HER2-Negative Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in Nashville (Biospecimen

Not yet recruiting
  • Metastatic HER2-Negative Breast Carcinoma
  • Metastatic Triple-Negative Breast Carcinoma
  • Biospecimen Collection
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Mar 3, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in United States (VS-6766 and sotorasib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766) and sotorasib
  • Washington, District of Columbia
  • +6 more
Jan 31, 2023

Fatigue Trial in United States (armodafinil 150 mg, Placebo, armodafinil 250 mg)

Completed
  • Fatigue
  • armodafinil 150 mg
  • +2 more
  • Anchorage, Alaska
  • +364 more
Nov 3, 2022

Breast Cancer, Risk Reduction Trial in Oxford (Prepectoral implant-based immediate breast reconstruction)

Enrolling by invitation
  • Breast Cancer
  • Risk Reduction
  • Prepectoral implant-based immediate breast reconstruction
  • Oxford, Oxfordshire, United Kingdom
    Surigcal Intervention Trials Unit (SITU), Nuffield Department of
Oct 30, 2023

COlorectal BReath Analysis (COBRA2)

Recruiting
  • Colorectal Cancer
  • Breath test
  • London, United Kingdom
  • +4 more
Apr 25, 2023

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8

Not yet recruiting
  • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
  • +3 more
  • PD-L1/IDO Peptide Vaccine
  • Pembrolizumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Apr 24, 2023

Patients With Neuroendocrine Cancer of the Cervix

Recruiting
  • Cervical Large Cell Neuroendocrine Carcinoma
  • +21 more
  • Follow-Up
  • Medical Chart Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Diabete Type 2, Obesity Trial in Orlando (HU6)

Not yet recruiting
  • Diabete Type 2
  • Obesity
  • Orlando, Florida
    AdventHealth Translational Research Institute
Oct 23, 2023

Testing Circulating Tumour DNA for Homologous Recombination Gene

Recruiting
  • Circulating Tumor DNA
  • Metastatic Prostate Cancer
  • Blood sample
  • Urine sample
  • Tours, France
    University hospital
Sep 6, 2022

The Pandemic's Effect on Diagnosis and Treatment of Rectal

Recruiting
  • Rectal Cancer
  • Diagnosed during or not during the pandemic
  • Gothenburg, Sweden
    Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Apr 13, 2022

2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface

Recruiting
  • Dry Eye Disease
  • oGVHD
  • The standard care exam and biological specimens' collection
  • Baltimore, Maryland
    Geenebaum Cancer Center, University of Maryland Medical Center
Jun 2, 2022

Esophageal Cancer Trial in Luoyang (Camrelizumab)

Recruiting
  • Esophageal Cancer
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Jan 20, 2022

Cancer Trial in Seattle (Financial navigation, Enhanced usual care)

Recruiting
  • Cancer
  • Financial navigation
  • Enhanced usual care
  • Seattle, Washington
    Kaiser Permanente Washington Health Research Institute
Aug 15, 2022

HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

Active, not recruiting
  • HER2-positive Breast Cancer
  • TQB2440 injection + Trastuzumab + Docetaxel
  • Perjeta + Trastuzumab + Docetaxel
  • Chongqing, Chongqing, China
  • +5 more
Aug 3, 2023

Melanoma (Skin) Trial in Stockholm (LifeChamps Platform)

Active, not recruiting
  • Melanoma (Skin)
  • LifeChamps Platform
  • Stockholm, Sweden
    Academic Primary Health Care Centre
Aug 6, 2023